Prevalence of cardiometabolic co-morbidities in patients with vs persons without chronic hepatitis B: The FitLiver cohort study

Table 1 Baseline demographic characteristics of patients with chronic hepatitis B and a comparison group without chronic hepatitis B, matched on age, sex, body mass index, and country-of-birth, n (%)

	All participants	Chronic hepatitis B	Comparison group	P value
Participants, n	147	98	49
Age, years (range)	45 (19-78)	44 (25-74)	46 (19-78)	0.15
Sex, female	74 (50)	50 (51)	24 (49)	0.86
Country of birth				0.30
Denmark	20 (14)	12 (12)	8 (16)
Eastern Europe	9 (6)	5 (5)	4 (8)
Turkey	28 (19)	21 (21)	7 (14)
MENA region	19 (13)	9 (9)	10 (20)
Sub-Saharan Africa	11 (7)	7 (7)	4 (8)
Asia	58 (39)	43 (44)	15 (31)
South America	2 (1)	1 (1)	1 (2)
Highest level of education				0.50
Primary school	17 (12)	14 (14)	3 (6)
High school	10 (7)	6 (6)	4 (8)
Vocational education	31 (21)	20 (20)	11 (22)
Academic higher education	85 (58)	54 (55)	31 (63)
Employment				0.29
Student	11 (7)	7 (7)	4 (8)
Employed/self-employed	109 (74)	68 (69)	41 (84)
Unemployed	10 (7)	8 (8)	2 (4)
Retired	14 (10)	12 (12)	2 (4)
Relationship status
Married or with a partner	111 (76)	79 (80)	32 (65)	< 0.05
Substance intake
Alcohol use currently	76 (52)	42 (43)	34 (69)	< 0.05
Smoking ever	61 (41)	41 (42)	20 (41)	1.00
Drug-use ever	12 (8)	7 (7)	5 (10)	0.53

The groups were compared using Fisher’s exact test. A P value of < 0.05 is considered statistically significant. MENA: Middle East and Northern Africa.